Project Grant R01HL181422
Award Date 6/1/26
Completion Date 2/28/30
Dollars Obligated $747K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Madison, WI 53715, USA
Similar Awards
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Wisconsin–Madison a Project Grant totaling $639,822 under the Cardiovascular Diseases Research program (CFDA 93.837) on September 15, 2025, with a completion date of June 30, 2029. This research project investigates the role of neutral sphingomyelinase (NSMase), a membrane enzyme involved in sphingolipid metabolism, in cardiac mechanosensing and signal transduction. The research...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Wisconsin-Madison a Project Grant of $151,040 under the Cardiovascular Diseases Research program (CFDA 93.837) on February 5, 2026, with completion targeted for August 31, 2026. This fellowship training award supports research investigating the assembly and localization of human ether-à-go-go-related gene (hERG) channel cotranslational complexes in cardiac tissue. The project aims to...
- Federal Project Grant Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded a $521,101 Project Grant to the University of Wisconsin-Madison on June 15, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) with a completion date of February 28, 2031. This grant supports research investigating the role of macrophages and hematopoietic stem cell (HSC) trogocytosis in the bone marrow niche. The research focuses on understanding how HSCs acquire macrophage-associated...
- Federal Project Grant Summary The University of Washington received a $663,578 Project Grant award dated August 15, 2025, from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The award funds research through May 31, 2029, addressing diagnostic challenges in inflammatory and genetic cardiomyopathies, specifically cardiac sarcoidosis. The project delivers comprehensive "deep phenotyping" services combining genetic...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Wisconsin–Madison a $1.45 million Project Grant on June 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct a five-year research initiative concluding May 31, 2031. The award supports mechanistic research into sex-specific cerebrovascular dysfunction in metabolic syndrome, with the primary objective of identifying subclinical changes in cerebral blood...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Medical College of Wisconsin, Inc. a Project Grant totaling $1,221,260 under the Cardiovascular Diseases Research program (CFDA 93.837) effective August 1, 2025, with completion targeted for May 31, 2030. The research project, titled "Post-Transcriptional Regulation of Vascular Homeostasis by RNA-Binding Proteins," focuses on identifying and characterizing key regulators of vascular...
- Federal Project Grant Award Summary The University of Michigan, through its Office of Research and Sponsored Projects, received a $651,349 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 1, 2025, with a completion date of May 31, 2029. This award funds research investigating stoichiometric, adhesion, and contractile deficits in desmoplakin cardiomyopathy, a condition caused by genetic...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Washington a $1.66 million Project Grant (CFDA 93.837: Cardiovascular Diseases Research) effective September 24, 2025, through June 30, 2029, to conduct proteomic and genomic discovery research targeting atrial cardiopathy-related cardiovascular outcomes. The research leverages proteomics and genomic methods across diverse primary and secondary prevention populations to identify...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded a $776,791 Project Grant to The Washington University on June 4, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837). The award supports research investigating how sequence changes in intrinsically disordered regions (IDRs) of cardiac troponin affect protein function and cardiac contraction regulation. The project, which extends through April 30, 2029, addresses a critical gap in...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded a $694,754 Project Grant to The Washington University, Office of Sponsored Research Services, effective August 1, 2025, through May 31, 2030, under the Cardiovascular Diseases Research program (CFDA 93.837). This research initiative focuses on developing a mechanism-based precision medicine approach for treating cardiomyopathies by connecting molecular and cellular contractile dysfunction to patient...